Centers for Medicare & Medicaid Services' decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific evidence.

Mehdi H ShishehborChristopher J WhiteJoshua A BeckmanSanjay MisraPeter A SchneiderRobert A LooksteinVikram S KashyapDaniel ClairW Schuyler JonesKenneth RosenfieldBarry T KatzenMichael R Jaff

Published in: Vascular medicine (London, England) (2018)

Keyphrases

affordable care act
health insurance
healthcare
primary care
decision making
adverse drug
drug induced
emergency department